Reply to "CSF Amyloid-β Risk Stratification in CAA: A Missing Link for Anti-Amyloid Therapy Safety".
Free. We’ll email you when a new paper cites this one or any other paper you follow on JClub — at most one email a day. Every email has a one-tap unsubscribe.